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Background: To assess the impact of the pacemaker recorded data in the clinical management of the atrial fibrillation (AF) patients with 
implanted pacemaker (pacer).
Methods: Interrogations of 1000 pacemaker patients over a period of 1 year were reviewed by single investigator (JDF). Patients with dual chamber 
pacemakers (DDD, 80%) and electrocardiograms (ECG) showing AF or flutter were followed. Permanent AF patients with AF burden (% time spent in 
AF) 100% were excluded. Atrial oversensing and noise were carefully excluded. Patient information included age, co-morbidities, anticoagulation 
and rate/rhythm control medications. We aimed to identify potential candidates for antiarrhythmic drug therapy (AAD), anticoagulation, and cardio 
version.
Results: During the follow up, 84 (8.4%) patients (mean age 76 years) had alerts for AF. Of these, 35 (41%) were newly diagnosed with AF, 10 (12%) 
patients were started on AAD therapy and 11(13%) patients underwent cardioversion based on the information obtained on pacer interrogation. Of 
the 84 patients, 45 (53%) (average CHADS2 score >2) were placed or remained on anticoagulation. Patients 21 (25%) who had AF burden <10% are 
not on anticoagulation.
Conclusions: Pacemakers provide useful diagnostic information and this can be used in the clinical management of the AF but the resources 
should be exploited. Patients and physicians should be educated on using this data in their practice to change the management of AF.
